Get the Stockscreener App
22.62
2.31%
0.51
After Hours:
22.50
-0.12
-0.53%
Enovis Corp stock is traded at $22.62, with a volume of 627.90K.
It is up +2.31% in the last 24 hours and up +1.34% over the past month.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
See More
Previous Close:
$22.11
Open:
$22.65
24h Volume:
627.90K
Relative Volume:
0.59
Market Cap:
$1.29B
Revenue:
$2.25B
Net Income/Loss:
$-1.18B
P/E Ratio:
-1.0931
EPS:
-20.6926
Net Cash Flow:
$19.92M
1W Performance:
-1.39%
1M Performance:
+1.34%
6M Performance:
-24.65%
1Y Performance:
-42.59%
1-Day Range:
$21.80
$23.03
1-Week Range:
$21.40
$23.29
52-Week Range:
$21.00
$39.75
Enovis Corp Stock (ENOV) Company Profile
Name
Enovis Corp
Sector
Industry
Phone
(302) 252-9160
Address
2711 CENTERVILLE ROAD, WILMINGTON
Compare ENOV vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENOV
Enovis Corp
|
22.62 | 1.27B | 2.25B | -1.18B | 19.92M | -20.69 |
ABT
Abbott Laboratories
|
104.83 | 180.82B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
327.65 | 125.72B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.89 | 111.16B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
69.78 | 101.28B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
82.67 | 47.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-26 | Initiated | BTIG Research | Buy |
| Oct-03-24 | Initiated | JMP Securities | Mkt Outperform |
| Jun-13-24 | Initiated | JP Morgan | Neutral |
| Feb-13-24 | Initiated | Stephens | Overweight |
| Jan-22-24 | Initiated | UBS | Buy |
| Jan-03-24 | Initiated | William Blair | Outperform |
| Dec-15-23 | Reiterated | Needham | Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Jun-26-23 | Initiated | Needham | Buy |
| May-12-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Oct-11-22 | Initiated | Goldman | Buy |
| Sep-12-22 | Initiated | Canaccord Genuity | Buy |
| Sep-12-22 | Initiated | Evercore ISI | Outperform |
| Jun-28-22 | Initiated | Argus | Hold |
| Jun-27-22 | Resumed | Loop Capital | Buy |
| Jun-16-22 | Initiated | Wells Fargo | Equal Weight |
View All
Enovis Corp Stock (ENOV) Latest News
Enovis Delivers 7% Sales Growth in Q2, Raises Full-Year Outlook - MSN
DAVENPORT & Co LLC Cuts Stock Holdings in Enovis Corporation $ENOV - MarketBeat
Enovis Corporation (NYSE:ENOV) Q4 2025 earnings call transcript - MSN
Wall Street Analysts See a 100.71% Upside in Enovis (ENOV): Can the Stock Really Move This High? - Yahoo Finance
Wall Street experts predict Enovis (ENOV) could climb by 100.71%: Is such a surge truly possible for the stock? - Bitget
Enovis (NYSE:ENOV) Stock Rating Lowered by Wall Street Zen - MarketBeat
Enovis Corporation (NYSE:ENOV) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Tranche Update on Enovis Corporation's Equity Buyback Plan announced on February 16, 2018. - marketscreener.com
Wells Fargo Sticks to Its Buy Rating for Enovis (ENOV) - The Globe and Mail
Enovis (NYSE:ENOV) Rating Increased to Strong-Buy at Wells Fargo & Company - MarketBeat
Enovis Gains Market Attention Across Nyse Composite Trends - Kalkine Media
UBS reiterates Enovis stock Buy rating on growth outlook By Investing.com - Investing.com Australia
UBS reiterates Enovis stock Buy rating on growth outlook - Investing.com
Enovis (ENOV) to report earnings tomorrow: Here is what to expect - MSN
Wells Fargo Maintains Enovis Corp(ENOV.US) With Buy Rating, Cuts Target Price to $42 - 富途牛牛
Signal Recap: Can Enovis Corporation maintain its current growth rate2026 Sector Review & Trade Opportunity Analysis - baoquankhu1.vn
Engert Oliver, chief administrative officer, buys Enovis Corp (ENOV) shares By Investing.com - Investing.com South Africa
Insider Buying: Oliver Engert Acquires Shares of Enovis Corp (EN - GuruFocus
Oliver Engert Buys 1,000 Shares of Enovis (NYSE:ENOV) Stock - MarketBeat
Engert Oliver, chief administrative officer, buys Enovis Corp (ENOV) shares - Investing.com
Enovis tops profit expectations but revenue falls short - MSN
[Form 4] Enovis CORP Insider Trading Activity - Stock Titan
Invenomic Capital Management LP Has $21.62 Million Holdings in Enovis Corporation $ENOV - MarketBeat
ENOV SEC FilingsEnovis Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Enovis Corporation $ENOV Stake Lowered by Dorsey Asset Management LLC - MarketBeat
How The Enovis (ENOV) Story Is Shifting Around Growth Margins And Cash Generation - Yahoo Finance
Enovis (NYSE:ENOV) Stock Rating Upgraded by Wall Street Zen - MarketBeat
ESAB,ENOV Options - Finviz
Engert Oliver, chief administrative officer at Enovis, buys $23,930 in ENOV By Investing.com - Investing.com South Africa
Enovis Corporation (ENOV): Orthopedic innovation and growth potential drive analyst confidence - MSN
Top Enovis Insider Makes Bold Move With Fresh Stock Purchase - TipRanks
Engert Oliver, chief administrative officer at Enovis, buys $23,930 in ENOV - Investing.com India
Enovis (ENOV) CAO Oliver Engert buys 1,000 shares in open-market trade - Stock Titan
Barclays PLC Lowers Stake in Enovis Corporation $ENOV - MarketBeat
Enovis (ENOV) Is Down 5.5% After 2025 Loss And 2026 Revenue Outlook UpdateHas The Bull Case Changed? - simplywall.st
Enovis (NYSE:ENOV) Insider Oliver Engert Purchases 750 Shares - MarketBeat
Enovis (ENOV) CFO awarded 47,974 RSUs as 3,167 shares withheld for taxes - Stock Titan
Enovis (ENOV) legal chief receives 25,586-share award and tax withholding - Stock Titan
Enovis (ENOV) exec Louis Vogt awarded 36,247 RSUs; 1,980 shares withheld for taxes - Stock Titan
Unveiling Q4 Financial Results: How Enovis (NYSE:ENOV) Compares With Other Specialty Medical Devices & Supplies Stocks - Bitget
Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & SuppliesSpecialty Stocks - Yahoo Finance
A Look At Enovis (ENOV) Valuation After 2025 Earnings Losses And 2026 Revenue Guidance - simplywall.st
Enovis Outperforms Rennova Health in Key Financial Metrics - National Today
One Fund Bet $5 Million on Enovis Stock Last Quarter. Shares Surged 14% Post-Earnings - AOL.com
Aug Macro: Can Enovis Corporation ride the EV waveStop Loss & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Enovis (ENOV) CFO logs 2,220-share tax withholding, holds 113,789 shares - Stock Titan
Enovis (ENOV) HR chief has 1,173 RSU shares withheld to cover taxes - Stock Titan
Zacks Research Upgrades Enovis (NYSE:ENOV) to Strong-Buy - MarketBeat
Enovis (ENOV) Q4 earnings beat estimates - MSN
Insider Buying: Enovis (NYSE:ENOV) Insider Buys 1,000 Shares of Stock - MarketBeat
Enovis Corp Stock (ENOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):